ArticleCase reports in hematology2022

Daratumumab, Lenalidomide, and Dexamethasone (DRD), an Active Regimen in the Treatment of Immunosuppression-Associated Plasmablastic Lymphoma (PBL) in the Setting of Gorham's Lymphangiomatosis: Review of the Literature.

Matthew Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.